Remission of malabsorption in congenital intestinal lymphangiectasia following chemotherapy for lymphoma

Leuk Lymphoma. 1993 Sep;11(1-2):147-8. doi: 10.3109/10428199309054743.

Abstract

A 22-year-old female with protein losing enteropathy due to congenital intestinal lymphangiectasia who developed non-Hodgkin's lymphoma of the bone, is described. Complete remission of the lymphomatous process and disappearance of the gastrointestinal symptoms were achieved following treatment with combination chemotherapy and local irradiation.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Bone Neoplasms / drug therapy*
  • Child
  • Cyclophosphamide / administration & dosage
  • Doxorubicin / administration & dosage
  • Female
  • Humans
  • Lymphangiectasis, Intestinal / complications*
  • Lymphoma, B-Cell / drug therapy*
  • Malabsorption Syndromes / drug therapy*
  • Prednisone / administration & dosage
  • Vincristine / administration & dosage

Substances

  • Vincristine
  • Doxorubicin
  • Cyclophosphamide
  • Prednisone

Supplementary concepts

  • CHOP protocol